Platelets: Active players in the pathogenesis of arthritis and SLE

Nature Reviews Rheumatology

Volumn 8, Issue 9, 2012, Pages 534-542

  Boilard, Eric ^a   Blanco, Patrick ^b   Nigrovic, Peter A ^c  

^a LAVAL UNIVERSITY   (Canada)

^b BORDEAUX UNIVERSITY HOSPITAL   (France)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FC RECEPTOR; FIBRINOGEN RECEPTOR; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; P SELECTIN GLYCOPROTEIN LIGAND 1; PADGEM PROTEIN; PROSTACYCLIN; PROSTAGLANDIN H2; PROTEIN KINASE SYK; PROTEIN KINASE SYK INHIBITOR; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; THROMBOXANE A2; THROMBOXANE SYNTHASE; TIROFIBAN;

ANTIGEN PRESENTING CELL; ARTHRITIS; B LYMPHOCYTE; BLOOD VESSEL PERMEABILITY; CELL PROLIFERATION; CYTOKINE RELEASE; DISEASE SEVERITY; ENDOTHELIUM; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ADHERENCE; NONHUMAN; PATHOGENESIS; PLASMACYTOID DENDRITIC CELL; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN METABOLISM; PROTEIN PHOSPHORYLATION; REVIEW; RHEUMATOID ARTHRITIS; SHEAR STRESS; SIGNAL TRANSDUCTION; SYNOVIAL FLUID; SYNOVIOCYTE; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTOPENIA; THROMBOSIS;

ANIMALS; ARTHRITIS; AUTOIMMUNITY; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; PLATELET ACTIVATION; SYNOVIAL FLUID;

EID: 84866113069     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2012.118     Document Type: Review

References (127)

1. Bizzozero, G. Sur les petites plaques du sang des mammifères. Deuxième note [French]. Arch. Ital. Biol. 1, 1-4 (1882
2. George, J. N. Platelets. Lancet 355, 1531-1539 (2000 (Pubitemid 30237365)
3. HoTinNoe, B., Demers, M. & Wagner, D. D. How platelets safeguard vascular integrity. J. Thromb. Haemost. 9 (Suppl. 1), 56-65 (2011
4. Karas, S. P., Rosse, W. F. & Kurlander, R. J. Characterization of the IgG-Fc receptor on human platelets. Blood 60, 1277-1282 (1982 (Pubitemid 13211363)
5. Kao, K. J., Cook, D. J. & Scornik, J. C. Quantitative analysis of platelet surface HLA by W6/32 anti-HLA monoclonal antibody. Blood 68, 627-632 (1986 (Pubitemid 16008161)
6. Semple, J. W., Italiano, J. E. & Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol. 11, 264-274 (2011
7. Henn, V., Steinbach, S., Buchner, K., Presek, P. & Kroczek, R. A. The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40. Blood 98, 1047-1054 (2001
8. Henn, V. et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391, 591-594 (1998 (Pubitemid 28157601)
9. Aslam, R. et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107, 637-641 (2006 (Pubitemid 43076388)
10. Shiraki, R. et al. Expression of Toll-like receptors on human platelets. Thromb. Res. 113, 379-385 (2004 (Pubitemid 38844368)
11. Andonegui, G. et al. Platelets express functional Toll-like receptor4. Blood 106, 2417-2423 (2005 (Pubitemid 41510815)
12. Cognasse, F. et al. Evidence of Toll-like receptor molecules on human platelets. Immunol. Cell Biol. 83, 196-198 (2005 (Pubitemid 40469328)
13. Denis, M. M. et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell 122, 379-391 (2005 (Pubitemid 41127140)
14. Lindemann, S. et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J. Cell Biol. 154, 485-490 (2001 (Pubitemid 34286155)
15. Humphrey, J. H. & Jaques, R. Liberation of histamine and serotonin from platelets by antigen-antibody reactions in vitro. J. Physiol. 119, 43P (1953
16. Landry, P. et al. Existence of a microRNA pathway in anucleate platelets. Nat. Struct. Mol. Biol. 16, 961-966 (2009
17. Ehlers, R. et al. Targeting platelet-leukocyte interactions: Identification of the integrin Mac 1 binding site for the platelet counter receptor glycoprotein Ibalpha. J. Exp. Med. 198, 1077-1088 (2003 (Pubitemid 37248623)
18. Furie, B. & Furie, B. C. The molecular basis of platelet and endothelial cell interaction with neutrophils and monocytes: role of P selectin and the P selectin ligand, PSGL 1. Thromb. Haemost. 74, 224-227 (1995
19. Italiano, J. E., Jr & Battinelli, E. M. Selective sorting of alpha-granule proteins. J. Thromb. Haemost. 7 (Suppl. 1), 173-176 (2009
20. Italiano, J. E. Jr et al. Angiogenesis is regulated by a novel mechanism: pro-and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 111, 1227-1233 (2008 (Pubitemid 351213404)
21. Wolf, P. The nature and significance of platelet products in human plasma. Br. J. Haematol. 13, 269-288 (1967
22. Chargaff, E. & West, R. The biological significance of the thromboplastic protein of blood. J. Biol. Chem. 166, 189-197 (1946
23. Beyer, C. & Pisetsky, D. S. The role of microparticles in the pathogenesis of rheumatic diseases. Nat. Rev. Rheumatol. 6, 21-29 (2010
24. Gyorgy, B. et al. Membrane vesicles, current state of the-art: Emerging role of extracellular vesicles. Cell Mol. Life Sci. 68, 2667-2688 (2011
25. Distler, J. H. & Distler, O. Inflammation: Microparticles and their roles in inflammatory arthritides. Nat. Rev. Rheumatol. 6, 385-386 (2010
26. Distler, J. H. et al. Microparticles as regulators of inflammation: Novel players of cellular crosstalk in the rheumatic diseases. Arthritis Rheum. 52, 3337-3348 (2005 (Pubitemid 41612200)
27. Hristov, M., Erl, W., Linder, S. & Weber, P. C. Apoptotic bodies from endothelial cells enhance the number and initiate the differentiation of human endothelial progenitor cells in vitro. Blood 104, 2761-2766 (2004 (Pubitemid 39434959)
28. Connor, D. E., Exner, T., Ma, D. D. & Joseph, J. E. The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib. Thromb. Haemost. 103, 1044-1052 (2010
29. Perez-Pujol, S., Marker, P. H. & Key, N. S. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry A 71, 38-45 (2007 (Pubitemid 46207382)
30. Thiagarajan, P. & Tait, J. F. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J. Biol. Chem. 266, 24302-24307 (1991 (Pubitemid 21908941)
31. Schumacher, H. R., Jr Synovial membrane and fluid morphologic alterations in early rheumatoid arthritis: microvascular injury and virus-like particles. Ann. NY Acad. Sci. 256, 39-64 (1975
32. Palmer, D. G., Hogg, N. & Revell, P. A. Lymphocytes, polymorphonuclear leukocytes, macrophages and platelets in synovium involved by rheumatoid arthritis. A study with monoclonal antibodies. Pathology 18, 431-437 (1986 (Pubitemid 17231354)
33. Konttinen, Y. T., Gronblad, M., Bergroth, V., Santavirta, S. & Antti-Poika, I. Presence of platelet glycoproteins Ib and IIb-IIIa in inflammatory and noninflammatory synovium. J. Rheumatol. 16, 578-584 (1989 (Pubitemid 19154396)
34. Wang, F., Wang, N. S., Yan, C. G., Li, J. H. & Tang, L. Q. The significance of platelet activation in rheumatoid arthritis. Clin. Rheumatol. 26, 768-771 (2007 (Pubitemid 46554089)
35. Riddle, J. M. et al. A comparative study of platelet reactivity in arthritis. Ann. NY Acad. Sci. 370, 22-29 (1981 (Pubitemid 11049614)
36. Mac Mullan, P. A. et al. Platelet hyper-reactivity in active inflammatory arthritis is unique to the adenosine diphosphate pathway: A novel finding and potential therapeutic target. Rheumatology (Oxford) 49, 240-245 (2010
37. Knijff-Dutmer, E. A., Koerts, J., Nieuwland, R., Kalsbeek-Batenburg, E. M. & van de Laar, M. A. Elevated levels of platelet microparticles are associated with disease activity in rheumatoid arthritis. Arthritis Rheum. 46, 1498-1503 (2002 (Pubitemid 34620195)
38. Bunescu, A., Seideman, P., Lenkei, R., Levin, K. & Egberg, N. Enhanced Fcγ receptor I, αMβ2 integrin receptor expression by monocytes and neutrophils in rheumatoid arthritis: Interaction with platelets. J. Rheumatol. 31, 2347-2355 (2004 (Pubitemid 39603080)
39. Gasparyan, A. Y., Sandoo, A., Stavropoulos-Kalinoglou, A. & Kitas, G. D. Mean platelet volume in patients with rheumatoid arthritis: The effect of anti TNF α therapy. Rheumatol. Int. 30, 1125-1129 (2010
40. Jurk, K. & Kehrel, B. E. Platelets: physiology and biochemistry. Semin. Thromb. Hemost. 31, 381-392 (2005 (Pubitemid 41362342)
41. Sellam, J. et al. Increased levels of circulating microparticles in primary Sjogren's syndrome, systemic lupus erythematosus and rheumatoid arthritis and relation with disease activity. Arthritis Res. Ther. 11, R156 (2009
42. Goules, A. et al. Elevated levels of soluble CD40 ligand (sCD40L) in serum of patients with systemic autoimmune diseases. J. Autoimmun. 26, 165-171 (2006 (Pubitemid 43737334)
43. Pamuk, G. E. et al. Increased platelet activation markers in rheumatoid arthritis: Are they related with subclinical atherosclerosis? Platelets 19, 146-154 (2008 (Pubitemid 351302382)
44. Joseph, J. E., Harrison, P., Mackie, I. J., Isenberg, D. A. & Machin, S. J. Increased circulating platelet-leucocyte complexes and platelet activation in patients with antiphospholipid syndrome, systemic lupus erythematosus and rheumatoid arthritis. Br. J. Haematol. 115, 451-459 (2001 (Pubitemid 34203516)
45. Yaron, M. & Djaldetti, M. Platelets in synovial fluid. Arthritis Rheum. 21, 607-608 (1978
46. Endresen, G. K. & Forre, O. Human platelets in synovial fluid. A focus on the effects of growth factors on the inflammatory responses in rheumatoid arthritis. Clin. Exp. Rheumatol. 10, 181-187 (1992
47. Farr, M., Wainwright, A., Salmon, M., Hollywell, C. A. & Bacon, P. A. Platelets in the synovial fluid of patients with rheumatoid arthritis. Rheumatol. Int. 4, 13-17 (1984 (Pubitemid 14167216)
48. Endresen, G. K. Investigation of blood platelets in synovial fluid from patients with rheumatoid arthritis. Scand. J. Rheumatol. 10, 204-208 (1981 (Pubitemid 11004923)
49. Ginsberg, M. H., Breth, G. & Skosey, J. L. Platelets in the synovial space. Arthritis Rheum. 21, 994-995 (1978
50. Boilard, E. et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science 327, 580-583 (2010
51. Gyorgy, B. et al. Detection and isolation of cell-derived microparticles are compromised by protein complexes resulting from shared biophysical parameters. Blood 117, 39-48 (2011
52. Berckmans, R. J. et al. Cell-derived microparticles in synovial fluid from inflamed arthritic joints support coagulation exclusively via a factor VII-dependent mechanism. Arthritis Rheum. 46, 2857-2866 (2002 (Pubitemid 35315876)
53. Semple, J. W. et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T cell reactivity. Blood 87, 4245-4254 (1996 (Pubitemid 26152268)
54. Moroi, M. & Jung, S. M. Platelet glycoprotein VI: Its structure and function. Thromb. Res. 114, 221-233 (2004 (Pubitemid 39286008)
55. Berckmans, R. J. et al. Synovial microparticles from arthritic patients modulate chemokine and cytokine release by synoviocytes. Arthritis Res. Ther. 7, R536-R544 (2005
56. Kyburz, D. & Corr, M. The KRN mouse model of inflammatory arthritis. Springer Semin. Immunopathol. 25, 79-90 (2003 (Pubitemid 37000040)
57. Schmitt-Sody, M. et al. Selective inhibition of platelets by the GPIIb/IIIa receptor antagonist Tirofiban reduces leukocyte-endothelial cell interaction in murine antigen-induced arthritis. Inflamm. Res. 56, 414-420 (2007 (Pubitemid 350160420)
58. Schmitt-Sody, M. et al. In vivo interactions of platelets and leucocytes with the endothelium in murine antigen-induced arthritis: The role of P selectin. Scand. J. Rheumatol. 36, 311-319 (2007 (Pubitemid 47346919)
59. Nieswandt, B., Pleines, I. & Bender, M. Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic stroke. J. Thromb. Haemost. 9 (Suppl. 1), 92-104 (2011
60. Garcia, A. E., Mada, S. R., Rico, M. C., Dela Cadena, R. A. & Kunapuli, S. P. Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis. PLoS ONE 6, e26035 (2011
61. Kawashiri, S. Y., Taguchi, M., Kawakami, A. & Eguchi, K. Clopidogrel-associated acute arthritis. Rheumatol. Int. 32, 449-50 (2012
62. Kanadiya, M. K., Singhal, S. & Koshal, V. B. Prasugrel as a safe alternative for clopidogrel-associated arthritis. J. Invasive Cardiol. 23, E137-E138 (2011
63. Garg, A., Radvan, J. & Hopkinson, N. Clopidogrel associated with acute arthritis. BMJ 320, 483 (2000 (Pubitemid 30173121)
64. Tayyareci, Y. Acute arthritis associated with loading dose of clopidogrel. J. Clin. Rheumatol. 14, 254-255 (2008
65. Chen, K. K., Ginges, I. & Manolios, N. Clopidogrel-associated acute arthritis. Intern. Med. J. 33, 618-619 (2003
66. Boulman, N., Rozenbaum, M., Slobodin, G. & Rosner, I. Acute polyarthritis associated with clopidogrel treatment. Isr. Med. Assoc. J. 7, 670-671 (2005 (Pubitemid 41489026)
67. Poole, A. et al. The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J. 16, 2333-2341 (1997 (Pubitemid 27258634)
68. Ueno, N., Takegoshi, Y., Kamei, D., Kudo, I. & Murakami, M. Coupling between cyclooxygenases and terminal prostanoid synthases. Biochem. Biophys. Res. Commun. 338, 70-76 (2005 (Pubitemid 41540538)
69. Brodie, M. J., Hensby, C. N., Parke, A. & Gordon, D. Is prostacyclin in the major pro-inflammatory prostanoid in joint fluid? Life Sci. 27, 603-608 (1980 (Pubitemid 11240068)
70. Honda, T., Segi-Nishida, E., Miyachi, Y. & Narumiya, S. Prostacyclin-IP signaling and prostaglandin E2-EP2/EP4 signaling both mediate joint inflammation in mouse collagen-induced arthritis. J. Exp. Med. 203, 325-335 (2006 (Pubitemid 43290842)
71. Chen, M. et al. Predominance of cyclooxygenase 1 over cyclooxygenase 2 in the generation of proinflammatory prostaglandins in autoantibody-driven K/BxN serum-transfer arthritis. Arthritis Rheum. 58, 1354-1365 (2008 (Pubitemid 351705925)
72. Mayeux, P. R., Kadowitz, P. J. & McNamara, D. B. Evidence for a bidirectional prostaglandin endoperoxide shunt between platelets and the bovine coronary artery. Biochim. Biophys. Acta 1011, 18-24 (1989 (Pubitemid 19074628)
73. Barry, O. P., Pratico, D., Lawson, J. A. & FitzGerald, G. A. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles. J. Clin. Invest. 99, 2118-2127 (1997 (Pubitemid 27203768)
74. Boilard, E. et al. Platelets participate in synovitis via Cox 1 dependent synthesis of prostacyclin independently of microparticle generation. J. Immunol. 186, 4361-4366 (2011
75. Schmitt-Sody, M. et al. Platelet-endothelial cell interactions in murine antigen-induced arthritis. Rheumatology (Oxford) 44, 885-889 (2005 (Pubitemid 41511183)
76. Schmitt-Sody, M. et al. Platelet P selectin is significantly involved in leukocyte-endothelial cell interaction in murine antigen-induced arthritis. Platelets 18, 365-372 (2007 (Pubitemid 47123839)
77. Schmitt-Sody, M. et al. Endothelial iNOS versus platelet iNOS: responsibility for the platelet/leukocyte endothelial cell interaction in murine antigen induced arthritis in vivo. Inflamm. Res. 56, 262-268 (2007 (Pubitemid 47026294)
78. Zimmerman, G. A. & Weyrich, A. S. Immunology. Arsonists in rheumatoid arthritis. Science 327, 528-529 (2010
79. Brown, D. L., Cooper, A. G. & Bluestone, R. Exchange of IgM and albumin between plasma and synovial fluid in rheumatoid arthritis. Ann. Rheum. Dis. 28, 644-651 (1969
80. Levick, J. R. Permeability of rheumatoid and normal human synovium to specific plasma proteins. Arthritis Rheum. 24, 1550-1560 (1981 (Pubitemid 12253287)
81. Simkin, P. A. & Bassett, J. E. Pathways of microvascular permeability in the synovium of normal and diseased human knees. J. Rheumatol. 38, 2635-2642 (2011
82. Cloutier, N. et al. Platelets can enhance vascular permeability. Blood http://dx.doi.org/10.1182/blood 2012 02 413047.
83. Goerge, T. et al. Inflammation induces hemorrhage in thrombocytopenia. Blood 111, 4958-4964 (2008
84. Carbo, C., del Conde, I. & Duerschmied, D. Petechial bleeding after sunburn in a patient with mild thrombocytopenia. Am. J. Hematol. 84, 523 (2009
85. Binstadt, B. A. et al. Particularities of the vasculature can promote the organ specificity of autoimmune attack. Nat. Immunol. 7, 284-292 (2006
86. Endresen, G. K. Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis. Rheumatol. Int. 9, 19-24 (1989 (Pubitemid 19176934)
87. Zeller, J., Weissbarth, E., Baruth, B., Mielke, H. & Deicher, H. Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activity. Arthritis Rheum. 26, 532-540 (1983 (Pubitemid 13120244)
88. Mercado, C. P. & Kilic, F. Molecular mechanisms of SERT in platelets: regulation of plasma serotonin levels. Mol. Interv. 10, 231-241 (2010
89. Krishnadas, R. & Cavanagh, J. Sustained remission of rheumatoid arthritis with a specific serotonin reuptake inhibitor antidepressant: A case report and review of the literature. J. Med. Case Reports 5, 112 (2011
90. Busso, N. et al. Essential role of platelet activation via protease activated receptor 4 in tissue factor-initiated inflammation. Arthritis Res. Ther. 10, R42 (2008
91. Flick, M. J. et al. The development of inflammatory joint disease is attenuated in mice expressing the anticoagulant prothrombin mutant W215A/E217A. Blood 117, 6326-6337 (2011
92. Ferro, D. et al. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus. Arthritis Rheum. 42, 2689-2697 (1999 (Pubitemid 30327192)
93. Nagahama, M. et al. Platelet activation markers and soluble adhesion molecules in patients with systemic lupus erythematosus. Autoimmunity 33, 85-94 (2001 (Pubitemid 32293976)
94. Tam, L. S. et al. Patients with systemic lupus erythematosus show increased platelet activation and endothelial dysfunction induced by acute hyperhomocysteinemia. J. Rheumatol. 30, 1479-1484 (2003
95. Lazarus, A. H. et al. Comparison of platelet immunity in patients with SLE and with ITP. Transfus. Sci. 22, 19-27 (2000 (Pubitemid 30195842)
96. Gori, A. M. et al. The balance between pro-and anti-inflammatory cytokines is associated with platelet aggregability in acute coronary syndrome patients. Atherosclerosis 202, 255-262 (2009
97. Navratil, J. S. et al. Platelet C4d is highly specific for systemic lupus erythematosus. Arthritis Rheum. 54, 670-674 (2006 (Pubitemid 43228646)
98. Batal, I. et al. Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: A pilot study. Lupus 21, 13-26 (2012
99. Peerschke, E. I., Yin, W. & Ghebrehiwet, B. Complement activation on platelets: Implications for vascular inflammation and thrombosis. Mol. Immunol. 47, 2170-2175 (2010
100. Pujol, M., Ribera, A., Vilardell, M., Ordi, J. & Feliu, E. High prevalence of platelet autoantibodies in patients with systemic lupus erythematosus. Br. J. Haematol. 89, 137-141 (1995
101. Kurata, Y. et al. Elevated platelet-associated IgG in SLE patients due to anti-platelet autoantibody: Differentiation between autoantibodies and immune complexes by ether elution. Br. J. Haematol. 85, 723-728 (1993 (Pubitemid 24003587)
102. Jouhikainen, T., Kekomaki, R., Leirisalo-Repo, M., Backlund, T. & Myllyla, G. Platelet autoantibodies detected by immunoblotting in systemic lupus erythematosus: Association with the lupus anticoagulant, and with history of thrombosis and thrombocytopenia. Eur. J. Haematol. 44, 234-239 (1990 (Pubitemid 20203065)
103. Kaplan, C., Champeix, P., Blanchard, D., Muller, J. Y. & Cartron, J. P. Platelet antibodies in systemic lupus erythematosus. Br. J. Haematol. 67, 89-93 (1987 (Pubitemid 17129617)
104. Howe, S. E. & Lynch, D. M. Platelet antibody binding in systemic lupus erythematosus. J. Rheumatol. 14, 482-486 (1987 (Pubitemid 17116928)
105. Bennett, A., Frampton, G. & Cameron, J. S. Platelet-associated IgG in idiopathic glomerulonephritis and the nephritis of systemic lupus erythematosus. Br. J. Haematol. 62, 695-703 (1986 (Pubitemid 16129167)
106. Michel, M. et al. Platelet autoantibodies and lupus-associated thrombocytopenia. Br. J. Haematol. 119, 354-358 (2002 (Pubitemid 35365481)
107. Blanco, P., Palucka, A. K., Gill, M., Pascual, V. & Banchereau, J. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294, 1540-1543 (2001 (Pubitemid 33063928)
108. Banchereau, J. & Pascual, V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity 25, 383-392 (2006 (Pubitemid 44354221)
109. Chan, V. S. et al. Distinct roles of myeloid and plasmacytoid dendritic cells in systemic lupus erythematosus. Autoimmun. Rev. http://dx.doi.org/10. 1016/j.autrev.2012.03.004
110. Banchereau, J. & Steinman, R. M. Dendritic cells and the control of immunity. Nature 392, 245-252 (1998 (Pubitemid 28155090)
111. Duffau, P. et al. Platelet CD154 potentiates interferon-α secretion by plasmacytoid dendritic cells in systemic lupus erythematosus. Sci. Transl. Med. 2, 47ra63 (2010
112. Desai-Mehta, A., Lu, L., Ramsey-Goldman, R. & Datta, S. K. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J. Clin. Invest. 97, 2063-2073 (1996 (Pubitemid 26143961)
113. Solanilla, A. et al. Platelet-associated CD154 in immune thrombocytopenic purpura. Blood 105, 215-218 (2005 (Pubitemid 40053085)
114. Nomura, S. et al. Platelet-derived microparticles cause CD154-dependent activation of dendritic cells. Platelets 23, 81-82 (2012
115. Elzey, B. D. et al. Platelet-mediated modulation of adaptive immunity. A communication link between innate and adaptive immune compartments. Immunity 19, 9-19 (2003 (Pubitemid 36859897)
116. Mehling, A. et al. Overexpression of CD40 ligand in murine epidermis results in chronic skin inflammation and systemic autoimmunity. J. Exp. Med. 194, 615-628 (2001 (Pubitemid 32844772)
117. Lood, C. et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 116, 1951-1957 (2010
118. Johnson, R. J. et al. Platelets mediate neutrophil-dependent immune complex nephritis in the rat. J. Clin. Invest. 82, 1225-1235 (1988
119. Zoja, C. & Remuzzi, G. Role of platelets in progressive glomerular diseases. Pediatr. Nephrol. 9, 495-502 (1995
120. Delmas, Y. et al. Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40. Kidney Int. 68, 2068-2078 (2005 (Pubitemid 43117781)
121. Tanaka, T. et al. Human platelets stimulate mesangial cells to produce monocyte chemoattractant protein 1 via the CD40/CD40 ligand pathway and may amplify glomerular injury. J. Am. Soc. Nephrol. 13, 2488-2496 (2002
122. Wada, T. et al. Monitoring urinary levels of monocyte chemotactic and activating factor reflects disease activity of lupus nephritis. Kidney Int. 49, 761-767 (1996 (Pubitemid 26093085)
123. Rovin, B. H. et al. Urine chemokines as biomarkers of human systemic lupus erythematosus activity. J. Am. Soc. Nephrol. 16, 467-473 (2005 (Pubitemid 41725143)
124. Li, Y. et al. Urinary biomarkers in lupus nephritis. Autoimmun Rev. 5, 383-388 (2006 (Pubitemid 44143030)
125. Davi, G. & Patrono, C. Platelet activation and atherothrombosis. N. Engl. J. Med. 357, 2482-2494 (2007
126. Asanuma, Y. et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2407-2415 (2003 (Pubitemid 37542989)
127. Roman, M. J. et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N. Engl. J. Med. 349, 2399-2406 (2003) (Pubitemid 37542988)